CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
2.5614
0.39%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0272
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026207 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026207%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003985 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003985%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.01
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Eargo Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 2.5714
Open* 2.5614
1-Year Change* 292.37%
Day's Range* 2.5514 - 2.5614
52 wk Range 1.47-16.80
Average Volume (10 days) 43.85K
Average Volume (3 months) 2.15M
Market Cap 52.94M
P/E Ratio -100.00K
Shares Outstanding 20.76M
Revenue 41.11M
EPS -7.50
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Mar 21, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 8, 2023 2.5714 -0.0200 -0.77% 2.5914 2.6014 2.5614
Dec 7, 2023 2.5914 0.0000 0.00% 2.5914 2.5914 2.5914
Dec 6, 2023 2.6014 0.0200 0.77% 2.5814 2.6114 2.5714
Dec 5, 2023 2.5914 0.0100 0.39% 2.5814 2.5914 2.5814
Dec 4, 2023 2.5914 0.0100 0.39% 2.5814 2.5914 2.5514
Dec 1, 2023 2.5814 0.0200 0.78% 2.5614 2.5814 2.5614
Nov 30, 2023 2.5914 0.0200 0.78% 2.5714 2.5914 2.5714
Nov 29, 2023 2.5914 0.0300 1.17% 2.5614 2.6014 2.5614
Nov 28, 2023 2.5914 0.0400 1.57% 2.5514 2.5914 2.5514
Nov 27, 2023 2.5814 0.0300 1.18% 2.5514 2.5814 2.5414
Nov 24, 2023 2.5614 0.0400 1.59% 2.5214 2.5714 2.5214
Nov 22, 2023 2.5414 0.0000 0.00% 2.5414 2.5514 2.5214
Nov 21, 2023 2.5414 -0.0100 -0.39% 2.5514 2.5814 2.5414
Nov 20, 2023 2.5814 0.0300 1.18% 2.5514 2.5814 2.5514
Nov 17, 2023 2.5514 0.0000 0.00% 2.5514 2.5514 2.5414
Nov 16, 2023 2.5414 0.0000 0.00% 2.5414 2.5414 2.5414
Nov 15, 2023 2.5414 0.0000 0.00% 2.5414 2.5514 2.5314
Nov 14, 2023 2.5514 0.0100 0.39% 2.5414 2.5514 2.5414
Nov 13, 2023 2.5414 0.0000 0.00% 2.5414 2.5514 2.5414
Nov 10, 2023 2.5414 0.0200 0.79% 2.5214 2.5414 2.5214

Eargo, Inc. Events

Time (UTC) Country Event
Thursday, March 21, 2024

Time (UTC)

10:59

Country

US

Event

Q4 2023 Eargo Inc Earnings Release
Q4 2023 Eargo Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 37.248 66.522 69.154 32.79 23.163
Revenue 37.248 66.522 69.154 32.79 23.163
Cost of Revenue, Total 22.988 27.956 21.873 15.79 11.423
Gross Profit 14.26 38.566 47.281 17 11.74
Total Operating Expense 149.779 223.229 105.652 76.826 55.293
Selling/General/Admin. Expenses, Total 107.206 135.641 70.107 48.195 33.791
Research & Development 18.813 25.232 12.045 12.841 9.52
Unusual Expense (Income) 0.772 34.4 1.627 0 0.559
Operating Income -112.531 -156.707 -36.498 -44.036 -32.13
Interest Income (Expense), Net Non-Operating -44.856 -1.047 -1.883 -0.084 -0.26
Other, Net 0 0 -1.474 -0.366 -1.403
Net Income Before Taxes -157.387 -157.754 -39.855 -44.486 -33.793
Net Income After Taxes -157.487 -157.754 -39.855 -44.486 -33.793
Net Income Before Extra. Items -157.487 -157.754 -39.855 -44.486 -33.793
Net Income -157.487 -157.754 -39.855 -44.486 -33.793
Income Available to Common Excl. Extra. Items -157.487 -157.754 -30.015 -44.486 -33.766
Income Available to Common Incl. Extra. Items -157.487 -157.754 -30.015 -44.486 -33.766
Diluted Net Income -157.487 -157.754 -30.015 -44.486 -33.766
Diluted Weighted Average Shares 3.96843 1.94497 1.91233 4.27156 4.27156
Diluted EPS Excluding Extraordinary Items -39.6849 -81.1086 -15.6955 -10.4145 -7.90484
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -39.5585 -63.422 -14.8447 -10.4145 -7.77398
Total Adjustments to Net Income 0 0 9.84 0 0.027
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 8.108 11.813 12.917 7.908 7.247
Revenue 8.108 11.813 12.917 7.908 7.247
Cost of Revenue, Total 6.477 6.691 6.757 6.007 4.733
Gross Profit 1.631 5.122 6.16 1.901 2.514
Total Operating Expense 33.914 34.605 36.801 33.954 39.462
Selling/General/Admin. Expenses, Total 22.073 23.309 25.92 22.984 30.078
Research & Development 5.364 4.605 4.124 4.963 3.879
Operating Income -25.806 -22.792 -23.884 -26.046 -32.215
Interest Income (Expense), Net Non-Operating 0.654 0.87 -19.787 -24.581 -0.229
Other, Net 0
Net Income Before Taxes -25.152 -21.922 -43.671 -50.627 -32.444
Net Income After Taxes -25.152 -21.922 -43.771 -50.627 -32.444
Net Income Before Extra. Items -25.152 -21.922 -43.771 -50.627 -32.444
Net Income -25.152 -21.922 -43.771 -50.627 -32.444
Income Available to Common Excl. Extra. Items -25.152 -21.922 -43.771 -50.627 -32.444
Income Available to Common Incl. Extra. Items -25.152 -21.922 -43.771 -50.627 -32.444
Diluted Net Income -25.152 -21.922 -43.771 -50.627 -32.444
Diluted Weighted Average Shares 20.7458 20.7344 9.96944 1.96987 1.96821
Diluted EPS Excluding Extraordinary Items -1.21239 -1.05728 -4.39052 -25.7007 -16.484
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -1.21239 -1.05728 -4.39052 -25.7007 -16.0917
Unusual Expense (Income) 0 0 0 0.772
Total Adjustments to Net Income 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 116.03 139.632 222.457 19.913 55.689
Cash and Short Term Investments 101.238 110.5 212.185 13.384 51.051
Cash & Equivalents 101.238 110.5 212.185 13.384 51.051
Total Receivables, Net 1.91 12.547 3.793 2.051 0.965
Accounts Receivable - Trade, Net 1.91 12.547 3.793 2.051 0.965
Total Inventory 5.036 5.712 2.739 2.88 2.16
Prepaid Expenses 7.846 10.873 3.74 1.598 1.363
Other Current Assets, Total 0 0.15
Total Assets 132.078 160.111 232.632 27.305 59.042
Property/Plant/Equipment, Total - Net 13.206 16.716 9.113 5.4 2.949
Property/Plant/Equipment, Total - Gross 26.346 25.614 14.2 8.119 4.16
Accumulated Depreciation, Total -13.14 -8.898 -5.087 -2.719 -1.211
Other Long Term Assets, Total 0.906 1.209 1.062 1.992 0.404
Total Current Liabilities 25.251 72.383 23.718 22.29 12.66
Accounts Payable 6.504 9.053 6.02 5.428 5.175
Accrued Expenses 12.763 9.609 14.358 9.939 5.723
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 3.333 0 4.8 0
Other Current Liabilities, Total 5.984 50.388 3.34 2.123 1.762
Total Liabilities 31.224 90.947 38.721 30.528 20.026
Total Long Term Debt 0 11.924 14.837 7.842 7.071
Long Term Debt 0 11.924 14.837 7.842 7.071
Other Liabilities, Total 5.973 6.64 0.166 0.396 0.295
Total Equity 100.854 69.164 193.911 -3.223 39.016
Redeemable Preferred Stock 0 0 0 152.88 152.015
Common Stock 0.002 0.004 0.004 0 0
Additional Paid-In Capital 615.151 425.972 392.965 3.1 1.718
Retained Earnings (Accumulated Deficit) -514.299 -356.812 -199.058 -159.203 -114.717
Total Liabilities & Shareholders’ Equity 132.078 160.111 232.632 27.305 59.042
Total Common Shares Outstanding 20.727 1.96536 1.91233 4.27156 4.27156
Goodwill, Net 0.873 0.873
Intangibles, Net 1.063 1.681
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 56.692 72.935 97.637 116.03 99.242
Cash and Short Term Investments 46.023 60.779 79.776 101.238 88.075
Cash & Equivalents 46.023 60.779 79.776 101.238 88.075
Total Receivables, Net 1.012 0.961 1.92 1.91 1.156
Accounts Receivable - Trade, Net 1.012 0.961 1.92 1.91 1.156
Total Inventory 4.386 5.36 4.837 5.036 4.953
Prepaid Expenses 5.271 5.835 11.104 7.846 5.058
Total Assets 69.753 87.55 114.51 132.078 116.57
Property/Plant/Equipment, Total - Net 11.711 12.168 14.265 13.206 15.028
Property/Plant/Equipment, Total - Gross 27.79 27.384 28.578 26.346 26.889
Accumulated Depreciation, Total -16.079 -15.216 -14.313 -13.14 -11.861
Other Long Term Assets, Total 0.606 0.724 0.779 0.906 0.21
Total Current Liabilities 17.594 20.523 25.004 25.251 146.719
Accounts Payable 5.047 3.729 8.976 6.504 6.396
Accrued Expenses 7.203 9.777 8.17 12.763 11.247
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 5.344 7.017 7.858 5.984 4.076
Total Liabilities 24.624 27.733 32.17 31.224 152.894
Total Long Term Debt 0 0 0 0 0
Long Term Debt 0 0
Other Liabilities, Total 7.03 7.21 7.166 5.973 6.175
Total Equity 45.129 59.817 82.34 100.854 -36.324
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.002 0.002 0.002 0.002 0.004
Additional Paid-In Capital 623.828 621.188 618.559 615.151 434.2
Retained Earnings (Accumulated Deficit) -578.701 -561.373 -536.221 -514.299 -470.528
Total Liabilities & Shareholders’ Equity 69.753 87.55 114.51 132.078 116.57
Total Common Shares Outstanding 20.7624 20.7496 20.7418 20.727 1.97055
Goodwill, Net 0 0.873 0.873 0.873 0.873
Intangibles, Net 0.744 0.85 0.956 1.063 1.217
Current Port. of LT Debt/Capital Leases 0 125
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -157.487 -157.754 -39.855 -44.486 -33.793
Cash From Operating Activities -117.304 -98.456 -26.041 -39.108 -27.149
Cash From Operating Activities 5.458 4.202 2.525 1.528 0.695
Non-Cash Items 63.954 38.984 13.18 1.934 1.643
Cash Interest Paid 0.396 0.646 0.398 0.395 0.563
Changes in Working Capital -29.229 16.112 -1.891 1.916 4.306
Cash From Investing Activities -3.087 -7.587 -5.079 -3.859 -2.547
Capital Expenditures -3.087 -4.724 -5.079 -3.859 -2.547
Cash From Financing Activities 111.129 4.358 229.921 5.15 71.728
Financing Cash Flow Items -0.098 -0.04 -2.614 -0.758 0
Issuance (Retirement) of Stock, Net 27.732 4.398 220.202 0.908 72.417
Issuance (Retirement) of Debt, Net 83.495 0 12.333 5 -0.689
Net Change in Cash -9.262 -101.685 198.801 -37.817 42.032
Cash Taxes Paid 0.124 0.107 0.063
Other Investing Cash Flow Items, Total 0 -2.863
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -21.922 -157.487 -113.716 -63.089 -30.645
Cash From Operating Activities -21.33 -117.304 -96.862 -82.882 -20.35
Cash From Operating Activities 1.28 5.458 4.023 2.713 1.419
Non-Cash Items 3.757 63.954 40.587 12.232 3.663
Cash Taxes Paid
Cash Interest Paid
Changes in Working Capital -4.445 -29.229 -27.756 -34.738 5.213
Cash From Investing Activities -0.132 -3.087 -2.827 -2.352 -0.942
Capital Expenditures -0.132 -3.087 -2.827 -2.352 -0.942
Cash From Financing Activities 0 111.129 77.264 81.364 0.024
Issuance (Retirement) of Stock, Net 0 27.732 0.134 0.125 0.093
Issuance (Retirement) of Debt, Net 83.495 78.1 81.33
Net Change in Cash -21.462 -9.262 -22.425 -3.87 -21.268
Other Investing Cash Flow Items, Total 0 0 0
Financing Cash Flow Items 0 -0.098 -0.97 -0.091 -0.069
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Patient Square Capital, LP Private Equity 76.2488 15821299 0 2023-06-30 MED
The Charles and Helen Schwab Living Trust Corporation 5.226 1084371 0 2023-03-31
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.1217 232744 -49188 2023-06-30 LOW
New Enterprise Associates (NEA) Venture Capital 1.0019 207886 -18114 2023-06-30 LOW
Nan Fung Life Sciences Venture Capital 0.7128 147904 0 2023-06-30 LOW
Gilde Healthcare Partners B.V. Venture Capital 0.4504 93465 -56369 2022-10-11 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.411 85290 15766 2023-06-30 LOW
Nantahala Capital Management, LLC Hedge Fund 0.2603 54002 0 2023-06-30 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.2491 51685 0 2023-06-30 LOW
Renaissance Technologies LLC Hedge Fund 0.224 46480 -2700 2023-06-30 HIGH
Wu (David James) Individual Investor 0.1227 25463 0 2023-03-31 HIGH
Millennium Management LLC Hedge Fund 0.0907 18813 -17277 2023-06-30 HIGH
BofA Global Research (US) Research Firm 0.0571 11844 51 2023-06-30 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.0442 9173 0 2023-06-30 LOW
CIBC Asset Management Inc. Investment Advisor 0.042 8715 0 2023-06-30 LOW
CSS, LLC Investment Advisor 0.0417 8656 250 2023-06-30 HIGH
Brownie (William H) Individual Investor 0.0307 6366 -1514 2023-08-17 LOW
Hughes (Douglas J) Individual Investor 0.0258 5353 3568 2022-11-22 HIGH
Morgan Stanley & Co. LLC Research Firm 0.0245 5086 0 2023-06-30 MED
Gormsen (Christian) Individual Investor 0.0231 4795 -58 2023-05-17 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Eargo, Inc. Company profile

Eargo (EAR) is a medical device company headquartered in San Jose, California. The company’s hearing loss solutions bring together proprietary technology, on-demand, licensed, hearing professionals and advanced personalised apps.

The company’s offering includes several hearing aid products such as the Eargo 6, Eargo 5, Eargo Neo HiFi and the Eargo Max.

Eargo stock was listed on the Nasdaq Stock Exchange under the ticker symbol EAR. The company’s initial public offering (IPO) took place on 16 October 2020, offering 7.9 million common shares each priced at $18. The IPO was upsized from the company’s original offering of nearly 6.7 million common stock shares priced between $14 and $16.

As of August 2022, Eargo does not pay a dividend to shareholders. 

You can follow the ups and downs of the Eargo stock price at Capital.com. Always stay on top of the latest price developments with our live EAR stock price chart.

Industry: Advanced Medical Equipment & Technology (NEC)

2665 North First Street
Suite 300
95134

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

Oil - Crude

71.59 Price
+0.230% 1D Chg, %
Long position overnight fee -0.0212%
Short position overnight fee -0.0007%
Overnight fee time 22:00 (UTC)
Spread 0.030

BTC/USD

41,188.80 Price
-6.110% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

1,982.04 Price
-1.130% 1D Chg, %
Long position overnight fee -0.0201%
Short position overnight fee 0.0118%
Overnight fee time 22:00 (UTC)
Spread 0.30

XRP/USD

0.62 Price
-6.650% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading